Abstract : We previously developed a new system of magnetic induction interstitial hyperthermia, implant heating system (IHS), and applied to oral cancer control. To overcome the limitations of this system, the present study dealt with new magnetic induction hyperthermia using Magnetic Cationic Liposomes (MCLs) which are injected into a tumor. We prepared a tongue tumor model using the transplantable rabbit VX-7 cells. MCL was injected into the tumor margins to heat the tumor selectively and induce blood vessel damage by heating. Two separated MCL injection sites were made by using Micro syringe pump and sandwiched the tumor on both sides.
Introduction
Hyperthermia induced by radio frequency (RF) has previously been used to treat head and neck cancer'-3). However, these studies have focused to treating metastasis to lymph nodes and not the primary lesion because of the difficulty in heating oral tumors4). We have explored for effective therapeutic modality to control malignant diseases, and previously developed a new system of magnetic induction interstitial hyperthermia, implant heating system (IHS), using ferromagnetic implants5,6). However there were two significant limitations of this system, if the long axes of the implants were not aligned parallel to the direction of the magnetic field, heat production would be limited, and surgical procedure was required for insertion of numerous implants into the tumor. The development of more exellent therapeutic modality for cancer control was thus needed to overcome these limitations.
The present study describes the use of Magnetite Cationic Liposomes (MCLs) for hyperthermia.
MCLs are colloids in which colloidal magnetites (Fe304 : average particle size lOnm) are coated with a phospholipid double membrane and have a positive charge on the surface. They readily bind to the negatively charged cell membrane due to electrostatic interaction7). They attach directly to tumor cells with high affinity and remain within the tissue for relatively long time. To test the effectiveness of new interstitial hyperthermia using MCLs against oral malignancies, we prepared a tongue tumor model with the use of transplantable rabbit VX-7 cells.
Materials and methods

Rabbit and VX-7 transplantable tumor
Female Japanese white rabbits (n = 8) weighting about 2.0Kg were used and rabbits were purchased from Chubu Kagaku Kogyo, (Nagoya, Japan). Animals were maintained under healthy conditions for 1 week after purchase, based on Nagoya University guidelines for experimental animals.
The VX-7 cells were employed as transplantable tumor in the rabbit tongue. VX-7 is a papilloma virus-induced squamous cell carcinoma, purchased from Chubu Kagaku Kogyo. The cells were cultured at 37°C in 5% CO, atmosphere in tissue culture media consisting of Eagles minimal essential medium (Gibco Grand Island, N.Y.USA) and supplemented with 10% fetal bovine serum, 5mM nonessential amino acids, 100u/m1 of penicillin, and 100u/m1 of streptomycin.
Preparation of tumor-bearing rabbits
Under pentobarbital anesthesia (Nembutal ® Abbott Lab, North Chicago, Illinois. USA), VX-7 cell suspensions (approximately 1 x 107cells) in100,u1 of phosphate buffered saline (0.05M Na phosphate and 0.15M NaCl, ph7.4) were injected into the left side of the tongue at the lingual margin. The tumors were allowed to grow for 9 days without any treatments.
Magnetite Cationic Liposomes (MCLs)
MCLs were prepared the method as described by Shinkai7 concentration (pH7.4, 0.05M Na phosphate+0.15M NaC1) by the addition of 10 fold concentrated phosphate-buffered saline maintained at 4°C until use.
Heating system
An alternating magnetic field was created (118KHz, 3840e) by using a horizontal coil (inner diameter : 70mm) with a transister inverter (LTG-100-05 ; Dai-ichi High Frequency Co. , Ltd., Tokyo, Japan) ( Fig. 2) . (Fig. 3A, B) . As a result, two separated MCL injection sites were made and sandwiched the tumor on both sides. Micro syringe pump (KD scientific Co., Ltd., USA) was used to perform the injections.
Hyperthermia in Rabbit tongue carcinoma
The rabbits (n = 8) were then separated into two groups. Group I (n=4) received hyperthermia and Group II, did not as control. The tissue was irradiated 5min after MCL injection. The tongue of the injected rabbit was placed at the center of the coil and irradiated for 30 min. The temperature within the tumor was measured using two thermometer probes (Anritsu Meter Tokyo, Japan) inserted into the center and marain of the tumor. (Fig. 30 .
Measurement of antitumor effects
The antitumor effect was evaluated by measuring the tumor volume and histologic observation.
The sizes of the tumors were measured under pentobarbital anesthesia every 3 days. The volume was determined with the following formula8) :
Tumor volume = 0.5 X (length X width2)
where the measurement were in millimeters. The antitumor effect was evaluated by comparing the two groups of rabbits. Tumor volume was compared between the treated (Group I) and control (Group II) groups using the X2 test. A p value of less than 0.05 was regarded as significant. Histological examination Twenty-eight days after the MCL injection, the rabbits were sacrificed under pentobarbital anesthesia , and the tongue, sentinel lymph nodes, heart, lung, spleen, liver, and kidney were examined. Tissues were fixed with 10% formalin solution. Longitudinal sections of the tongue were prepared. The specimens were embedded in paraffin, and sections (4p) were stained with hematoxylin and eosin for histopathologic examination.
Results
Heat generation by MCLs in an alternating field
As shown in Figure 4 , the temperature in the center of the transplanted tumors increased rapidly and reached 43°C after 3 min. In contrast, it took at least 5 min until the tumor margin was heated to 43°C .
These temperatures were maintained during irradiation. After irradiation, the temperature in the tumors recovered gradually, returning to base line within 5 min.
Tumor growth after hyperthermia
There were significant differences in the volumes of the experimental (irradiated) tumor compared to those of the control on the 3 th day after irradiation. In irradiated rabbits, the tumor of each rabbit almost completely disappeared until 18th day after irradiation (Fig.5) . No functional disorders were observed and irradiated rabbits maintained their weight (data not shown). In contrast, in control rabbits, tumor volume increased gradually, and all rabbits were dead by 12th day after irradiation . 
Histological findings
The tongues, obtained from the irradiated rabbits on 28th day after irradiation, showed no tumor cells and fibrous tissue completely replacing the implanted VX-7 tumor. Tongue muscle adjacent to the MCL injection sites did not exhibit any evidence of inflammation or necrosis .
The MCL were very localized and remained in the region of the MCL injection (Fig.7A) . The tongues of the control rabbits without irradiation were replaced with enlarged tumors. Tumor margins were well-vascularized and VX-7 invaded into the tongue muscle (Fig.7B) .
Tongues in the control rabbits 24h after the MCL injection had high accumulation of MCLs. The normal tissue adjacent to the MCL injection sites did not exhibit any evidence of inflammation or necrosis.
In sentinel lymph nodes, macrophages containing MCL granules were observed in the cortex and the lymphatic sinus. Little or no MCLs was detected in the red pulp of the spleen or Kupffers cells of the liver. There were no MCLs in other organs (data not shown).
Discussion
It has been described that magnetic induction hyperthermia therapy is effective to control malignant lesions9). This therapy takes advantage of the fact that, under a high-frequency magnetic field, fer- In group I rabbits, no tumor cells were evident and the tumors were completely replaced by fibrous tissue. MCLs were very localized and remained in the resion of the MCL injection (Arrows).
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romagnetic implants in the tumor generate heat due to eddy currents. Interstitial hyperthermia using ferromagnetic implants has been shown to have a favorable antitumor effect on rabbit tongue tumor 10 ).
However, one disadvantage of this system is that numerous ferromagnetic implants must be inserted into the tumor to achieve this effect. In addition, the long axes of the implants must be parallel to the direction of the magnetic field for maximal heat production. Therefore, since tumor margins are well-vascularized, and nearly all vessels can be destroyed in murine tissues by heating to 43°C for 30 minil), we tried to make two separated MCL injection sites and sandwiched the tumor on both sides. As a result, the target tissue was heated effectively using an alternating magnetic field (118Hz, 3840e). The temperature in the MCLs injected tumor increased rapidly, and uniform heating to the desired temperature was achieved without damaging the adjacent normal tissue. Moreover the present study showed that irradiated tumors revealed significant damage and they finally disappeared in MCLs injected tumor area.
This therapy overcame some of the complications of the former method and reduced the surgical invasion of the tissue.
The first attempt at using submicron particles has made by Gilchrist12), who has used Fe203 powder.
However there has been no specific affinity of the powder for the tumor cells. To increase its affinity and dispersion within the tumor tissue, magnetite cationic liposomes, which consist of colloidal magnetites (Fe304) coated with a liposomal membrane were developed by Shinkai"). The MCLs had such a high affinity for the cell membrane that they nearly all remained in the spleen and liver. These results corresponded with the findings in the rat liver by Gregoriadis"). MCLs which are taken into the systemic circulation are thought to be ultimately trapped by the lymphatic system.
The toxicity of MCLs has been examined. In this study, there also was no evidence of any systemic problems such as inflammation or necrosis near the sites of the MCL injections, and any swelling of the cervical lymph nodes into which some MCLs were taken. The present study confirms the effectiveness of interstitial hyperthermia using MCLs in oral cancer therapy. 
